Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Regulation01:25

Drug Regulation

3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

300
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
300
Additional Routes of Drug Administration01:18

Additional Routes of Drug Administration

5.1K
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
5.1K
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

283
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
283
Local Anesthetics: Common Agents and Their Applications01:23

Local Anesthetics: Common Agents and Their Applications

1.3K
Local anesthetics (LAs) are commonly used for various applications in medical and dental procedures. Some of the common agents used are cocaine, lidocaine, and bupivacaine.
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
1.3K
Drug Delivery: Overview01:16

Drug Delivery: Overview

1.3K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delivery of free amino acids into and through the stratum corneum of the skin using micro emulsions and microemulsion-based hydrogels: Formulation, characterization, and ex-<i>vivo</i> permeation studies.

Die Pharmazie·2023
Same author

[Practical problems with the use of topicals in geriatric dermatology].

Dermatologie (Heidelberg, Germany)·2023
Same author

[Alopecia areata with good response to tofacitinib].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2020
Same author

Pathomechanism of dupilumab-associated inflammatory eye symptoms.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

[Hyperhidrosis-aetiopathogenesis, diagnosis, clinical symptoms and treatment].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2018
Same author

Retarder action of isosorbide in a microemulsion for a targeted delivery of ceramide NP into the <i>stratum corneum</i>.

Die Pharmazie·2018

Related Experiment Video

Updated: May 2, 2026

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
11:07

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

2.6K

[Regulatory requirements for topical preparations].

J Wohlrab1, D Klauck, E Savtcheva

  • 1Universitätsklinik und Poliklinik für Dermatologie und Venerologie, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Strasse 40, 06097, Halle, Deutschland, johannes.wohlrab@medizin.uni-halle.de.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|March 14, 2014
PubMed
Summary

Understanding the regulatory classification of topical treatments is crucial for dermatologists. This knowledge impacts prescription practices, therapeutic freedom, and patient safety by clarifying liability and pharmacist intervention options.

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.4K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.4K

Related Experiment Videos

Last Updated: May 2, 2026

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
11:07

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

2.6K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.4K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.4K

Area of Science:

  • Dermatology
  • Pharmacology
  • Regulatory Science

Context:

  • Physicians require comprehensive knowledge of topical treatments, including pharmacological properties, efficacy, safety, pharmaceutical quality, and regulatory classification.
  • The regulatory framework significantly influences prescription practices and physician autonomy in dermatological care.
  • Current regulatory frameworks often lack transparency, impacting prescribers and manufacturers.

Purpose:

  • To elucidate the importance of regulatory classification for topical treatments in dermatological practice.
  • To highlight how regulatory status affects physician prescription habits and therapeutic choices.
  • To underscore the need for clarity in regulatory guidelines concerning prescription, reimbursement, and liability.

Summary:

  • Topical treatments in dermatology necessitate understanding beyond pharmacological aspects; regulatory classification is key.
  • Regulatory classification dictates prescribability, reimbursability, and liability for both proprietary and extemporaneous preparations.
  • Physicians must be aware of pharmacists' potential to alter prescriptions, which can impact treatment effectiveness and safety.

Impact:

  • Enhances physician awareness of regulatory implications in topical treatment selection.
  • Promotes informed prescription practices by clarifying the impact of regulatory status.
  • Aims to improve patient safety and therapeutic outcomes by ensuring clarity in the regulatory landscape and physician-pharmacist interactions.